Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q3 2021 · 10-Q
Revenue—
Net Income-$12.40M-$12.40MN/M vs Q3 2020 EPS Diluted-$0.13-$0.13N/M vs Q3 2020 Operating Income-$12,094,320N/M Operating Cash Flowderived-$1,846,826N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Apr 30, 2021 · filed Jun 21, 2021 · 52 d after period end